Description: Medical pharmacy is a rapidly evolving, innovative part of healthcare in the United States that includes Oncology, Gene, and Rare disease therapies. Over the past few years, cost and utilization trends have been disrupted by biosimilars, innovative therapies, site of care options, and the COVID-19 pandemic. This volatility can make assumption setting difficult, so take a deep dive into quantifying these impacts on the drug landscape. Gain an understanding of the significance of managing site of care. Learn through adjusted time-series forecasting where medical pharmacy drug spend is expected to grow with new drugs in the pipeline. Walk away with a better understanding of the market forces and care practices that drive trend, and how medical pharmacy is expected to change in the coming years.

Description: You’ve written the position papers, updated the models, and designed the required disclosures, but you may be wondering how to explain the results during interim financial reporting periods to company management as well as other stakeholders. This session will explore ways to adapt existing management reporting and offer ideas for new metrics. We will explore various methods for analyzing DAC amortization patterns, market risk benefit reserve patterns, and Liability for Future Benefits (LFPB) movements. In addition, this session will explore ways to integrate changes in LDTI with business planning and other broader business issues such as product pricing considerations and reinsurance strategy.

Description: Join us for an analysis of the impact of climate change on financial institution solvency, profitability, and how other key performance metrics are, or likely will be, required by financial regulators in most major economies in the very near future. Regulators are signaling that such impacts should be assessed through the use of scenario analysis, both qualitatively and quantitatively. Explore an overview of the emerging regulatory landscape for insurers as it relates to the disclosure of climate risk. After that, check out the mechanics and current best practices that actuaries and risk modelers may use in performing qualitative and quantitative climate risk scenario analyses, covering both physical and transition risks.

Description: The SOA's Aging and Retirement Strategic Research Program and Retirement Section partnered recently on a study that looked at what features retirees really want in their retirement plans. The study employed a survey technique commonly known as conjoint analysis, which represents an innovative new approach for SOA research and its retirement work, in particular. Uncover the results from this study as well as other innovative research that the Aging and Retirement program has recently undertaken, including applications of predictive analytics, DEI topics, and the impact of megatrends, and paradigm shifting on retirement.

Description: There are a number of ways insurers can deploy their capital. Lately the chase for yield, the need for long-tailed risk optimization, and a refocusing on core competencies have driven recent capital trends in the industry. M&A activity has been hot lately, private equity firms have grown their involvement in the industry, and insurers have continued to innovate in their funding of new business strain and investment into customer experience. In this session we will discuss these trends as we study insurer capital optimization through M&A, offshore, and structured reinsurance.

Description: What if a blood test can detect more than 50 types of cancer, including those in early stages? A biotech company, GRAIL, has developed the first-to-market Multi-Cancer Early Detection test and launched it for commercial use in 2021. Join us to learn how Munich Re and GRAIL are partnering to bring its Galleri test to the life insurance industry. You will also explore how we as an industry can help save lives by detecting cancer earlier and share perspectives on some early findings and cost-benefit analysis

Description: Listen to an update of the Social Security Program's financial status as presenters discuss recent proposals for modifying the program. At the conclusion of the session, enjoy a better understanding of the current status of the Social Security Program, its funding status, various challenges it faces, and a variety of suggestions that have been made to overcome those challenges.

Description: Join us for an in-depth discussion of the Society of Actuaries’ Quarterly Global Warming Report, which tracks accelerating global temperature trends and their implications for risk modeling. We’ll also highlight findings from the Actuarial Weather Extremes 2025 research series, which examines catastrophic floods, rising sea levels, and wildfire risks—events that are reshaping exposure and challenging traditional assumptions. This session will explore how these developments affect actuarial practice, pricing, and capital planning, and why actuaries are uniquely positioned to lead in managing climate-driven uncertainty.

Description: This session introduces you to the next level of gen AI: AI Assistants (also known as Custom GPTs, Gems, or Bots). An AI Assistant is a specialized, tailored version of a Large Language Model (LLM) that allows the user to produce a persistent, pre-programmed tool designed to handle complex, repetitive professional tasks with guaranteed consistency, accuracy, and alignment. We will move beyond casual prompting to explore the mechanical architecture required to build reliable, high-stakes assistants for a variety of applications.

Description: Join us for this popular annual webcast covering the latest considerations for the year's U.S. statutory financial reporting work. Get ready to hear from three expert speakers, who will discuss: Cash flow testing and this year’s New York and California holiday letters The impact of recent interest rate changes Potential changes to statutory financial reporting due to climate change Updates regarding Principle Based Reserves ASOP 22 Statements of Actuarial Opinion Based on Asset Adequacy Analysis for Life Insurance, Annuity, or Health Insurance Reserves and Other Liabilities